The new Lab21 Clinical Genomics Center at ITOR will allow cancer patients to benefit from new technology to receive real-time feedback and treatment plans tied to their cancer's specific DNA signature. Greenville Hospital System University Medical Center will be one of the first sites in the country to bring Ion Torrent next-generation gene-sequencing technology into a clinical environment for personalized oncology medicine studies.
Joe Stephenson
"Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey," said Dr. , medical director for GHS' Institute for Translational Oncology Research. "This genomics center is another major step towards fulfilling our vision to provide personalized cancer care — better enabling us to offer the right drug, at the right time, to the right patient."
Read the full story: http://hcp.lv/AlKgxQ
Source: bizjournals.com/PR Newswire
FDA Approves bluebird bio's Lovo-Cel Gene Therapy for Sickle Cell Disease
December 10th 2023The decision was supported by efficacy data from 36 patients from the ongoing phase 1/2 HGB-206 trial (NCT02140554) and 2 patients in the phase 3 HGB-210 trial (NCT04293185). It was the second approval from FDA for a gene therapy for sickle cell disease.
Read More
Cellular Therapies in Lymphoma Bring Hope, but Optimizing Their Use Remains a Challenge
December 10th 2023Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.
Read More